Gapping up
In reaction to strong earnings/guidance:
- APHA +32.7%, PINS +15.8%, SVMK +11.8%, FTNT +11.6%, SCPL +10.6%, BL +10.5%, MTZ +10.2%, CATM +10.1%, TNDM +9.6% (also announces offering of no-cost software update for t:slim X2 insulin pump customers in the US through 2020), IMGN +9.2%, NWL +8.7%, RDFN +7.5%, FND +7.3%, CORT +7.3%, FTAI +7%, CDNA +6.6%, ZIXI +6.6%, IMMR +6.4%, BGS +6.1%, CERS +5.5%, BLDR +4.2%, ESNT +3.6%, HMSY +3.5%, OLED +3.4%, NOG +3.3% (Founder, President and Chairman Emeritus Michael Reger is departing the company to pursue opportunities outside the Williston Basin; reports Q2 results), GPRO +3%, XPO +2.7%, X +2.6%, PVG +2.5%, SHO +2.4%, HTGC +2.2%, LOCO +2.2%, ALEX +2%, QRVO +1.6%, DVA +1.4%, IPHI +1.3%, XOG +1.2%, EOG +1.1%, HIG +1.1%, QSR +1.1%, XOM +1.1%, NE +1%, PBA +1%
Select cannabis related names showing strength:
- OGI +6.2%, ACB +6%, CRON +3.8%, CGC +2.5%, TLRY +2.1%, NBEV +2%, .
Other news:
- CLDR +15.6% (Carl Icahn discloses 12.62% active stake)
- FIZZ +6.1% (to join S&P SmallCap 600)
- GRUB +4.2% (to join S&P MidCap 400)
Analyst comments:
- FLS +3.9% (upgraded to Outperform from Neutral at Credit Suisse)
- FMC +1.1% (upgraded to Buy from Neutral at Goldman)